Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 3 10Phase 1/2 4Phase 1 4Phase 2/3 1

Status

Completed 4

Sponsor Class

OTHER 19NIH 5INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 3Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 3Prostatic Neoplasms 1Neoplasms 1

Interventions

pembrolizumab 242Carboplatin 137Nivolumab 132Gemcitabine 127Paclitaxel 116Cisplatin 105Cyclophosphamide 97Bevacizumab 93Dexamethasone 78Injections 75Pemetrexed 71Docetaxel 71Fluorouracil 68Capecitabine 65Rituximab 61Cetuximab 61atezolizumab 59130-nm albumin-bound paclitaxel 59Oxaliplatin 58Leucovorin 57Ipilimumab 54fludarabine 50Lenalidomide 47Azacitidine 40Irinotecan 39venetoclax 38Fulvestrant 38Albumin-Bound Paclitaxel 36Prednisone 35Trastuzumab 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × INDUSTRY × Mitoxantrone × Clear all
NCT02400281 2024-07-03

Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients

Arog Pharmaceuticals, Inc.

Phase 1/2 Completed
28 enrolled 15 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02626338 2023-12-20

Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML

Arog Pharmaceuticals, Inc.

Phase 1/2 Completed
16 enrolled 12 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02306291 2019-05-17

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

GlycoMimetics Incorporated

Phase 1/2 Completed
91 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00770848 2014-03-10

AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer

Amgen

Phase 1/2 Completed
162 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡